Aim: Assess the role of hybrid modality SPECT/CT versus planar scintigraphy in sentinel lymph node (SLN) identification in patients with breast cancer. Methods: Planar scintigraphy and hybrid modality SPECT/CT were performed in 23 women with breast cancer (mean age 59.5 years with range 25 - 82 years) with invasive breast cancer (T0, T1 and T2), without clinical evidence of axillary lymph node metastases (N0) and no remote metastases (M0), radiocolloid was injected in four subareolar sites. Planar and SPECT/CT images were separately interpreted. Results: SLNs were detected on lymphoscintigraphy in all patients (100%), taking into consideration both techniques (planar and SPECT-CT images). Planar images identified 45 SLNs in 23 women, with a mean of 1.95 per patient, whereas 56 SLNs were detected on SPECT/CT, increasing this mean to 2.43 per patient. Drainage to internal mammary lymph nodes was seen in 4 patients (17.39%). However, two foci of uptake were identified on planar image as hot SLN in two patients (8.69%); while they have been found as a false positive non-nodal site of uptake on SPECT/CT. Conclusion: SPECT/CT is more focused than planar scintigraphy in the detection of SLN in patients with breast cancer. It detects some lymph nodes not visible on planar images, excludes false positive uptake and exactly locates axillary and non-axillary SLNs.
References
[1]
Litvak, D.A. and Giuliano, A.E. (2002) The Results of the Department of Defense’s Breast Lymphatic Mapping Study. Annals of Surgical Oncology, 83, 428-429.
[2]
Schrenk, P., Rieger, R., Shamiyeh, A. and Wayand, W. (2000) Morbidity Following Sentinel Lymph Node Biopsy versus Axillary Lymph Node Dissection for Patients with Breast Carcinoma. Cancer, 88, 608-614. https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K
[3]
Chetty, U., Jack, W., Prescott, R.J., et al. (2000) Management of the Axilla in Operable Breast Cancer Treated by Breast Conservation: A Randomized Clinical Trial. Edinburgh Breast Unit. British Journal of Surgery, 87, 163-169. https://doi.org/10.1046/j.1365-2168.2000.01345.x
[4]
Nieweg, O.E., Jansen, L., Valdés Olmos, R.A., et al. (1999) Lymphatic Mapping and Sentinel Lymph Node Biopsy in Breast Cancer. European Journal of Nuclear Medicine, 26, S11-S16. https://doi.org/10.1007/s002590050572
[5]
Hill, A.D., Tran, K.N., Akhursl, T., et al. (1999) Lessons Learned from 500 Cases of Lymphatic Mapping for Breast Cancer. Annals of Surgery, 229, 528-535. https://doi.org/10.1097/00000658-199904000-00012
[6]
Bocher, M., Balan, A., Krausz, Y., Shrem, Y., Lonn, A., Wilk, M. and Chisin, R. (2000) Gamma Camera Mounted Anatomical X-Ray Tomography: Technology, System Characteristic and First Images. European Journal of Nuclear Medicine, 27, 619-627. https://doi.org/10.1007/s002590050555
[7]
Even-Sapir, E., Lerman, H., Lievshitz, G., et al. (2003) Lymphoscintigraphy for Sentinel Node Mapping Using a Hybrid SPECT/CT System. The Journal of Nuclear Medicine, 44, 1413-1420.
[8]
Keidar, Z., Israel, O. and Krausz, Y. (2003) SPECT/CT in Tumor Imaging: Technical Aspects and Clinical Applications. Seminars in Nuclear Medicine, 33, 205-218. https://doi.org/10.1053/snuc.2003.127310
[9]
Seo, Y., Mari, C. and Hasegawa, B.H. (2008) Technological Development and Advances in Single-Photon Emission Computed Tomography/Computed Tomography. Seminars in Nuclear Medicine, 38, 177-198. https://doi.org/10.1053/j.semnuclmed.2008.01.001
[10]
Kapteijn, B.A.E., Nieweg, O.E., Muller, S.H., et al. (1997) Validation of Gamma Probe Detection of the Sentinel Node in Melanoma. The Journal of Nuclear Medicine, 39, 362-366.
[11]
Rink, T., Heuser, T., Fitz, H., Schroth, H.-J., Weller, E. and Zippel, H.H. (2001) Lymphoscintigraphic Sentinel Node Imaging and Gamma Probe Detection in Breast Cancer with Tc-99m Nanocolloidal Albumin: Results of an Optimized Protocol. Clinical Nuclear Medicine, 26, 293-298. https://doi.org/10.1097/00003072-200104000-00002
[12]
Lerman, H., Lievshitz, G., Zak, O., et al. (2007) Improved Sentinel Node Identification by SPECT/CT in Overweight Patients with Breast Cancer. The Journal of Nuclear Medicine, 48, 201-206.
[13]
Estourgie, S.H., Tanis, P.J., Nieweg, O.E., et al. (2003) Should the Hunt for the Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients. Annals of Surgical Oncology, 10, 935-941. https://doi.org/10.1245/ASO.2003.02.015
[14]
van der Ploeg, I.M.C., Valdés Olmos, R.A., Nieweg, O.E., Rutgers, E.J.T., Kroon, B.B.R. and Hoefnagel, C.A. (2007) The Additional Value of SPECT/CT in Lymphatic Mapping in Breast Cancer and Melanoma. Journal of Nuclear Medicine, 48, 1756-1760. https://doi.org/10.2967/jnumed.107.043372
[15]
Lerman, H., Metser, U., Lievshitz, G., Sperber, F., Shneebaum, S. and Even-Sapir, E. (2006) Lymphoscintigraphic Sentinel Node Identification in Patients with Breast Cancer: The Role of SPECT-CT. European Journal of Nuclear Medicine and Molecular Imaging, 33, 329-337. https://doi.org/10.1007/s00259-005-1927-4
[16]
Husarik, D.B. and Steinert, H.C. (2007) Single-Photon Emission Computed Tomography/Computed Tomography for Sentinel Node Mapping in Breast Cancer. Seminars in Nuclear Medicine, 37, 29-33. https://doi.org/10.1053/j.semnuclmed.2006.08.001
[17]
Gallowitsch, H.J., Kraschl, P., Igerc, I., et al. (2007) Sentinel Node SPECT-CT in Breast Cancer. Can We Expect Any Additional and Clinically Relevant Information? Nuklearmedizin-NuclearMedicine, 46, 252-256. https://doi.org/10.3413/nukmed-0101
[18]
Van der Ploeg, I.M.C., Valdés Olmos, R.A., Kroon, B.B. and Nieweg, O.E. (2008) The Hybrid SPECT/CT as an Additional Lymphatic Mapping Tool in Patients with Breast Cancer. World Journal of Surgery, 32, 1930-1934. https://doi.org/10.1007/s00268-008-9618-5
[19]
Even-Sapir, E. (2006) Sentinel Node Scintigraphic Mapping Using SPECT/CT. In: Israel, O. and Goldsmith, S.J., Eds., Hybrid SPECT/CT Imaging in Clinical Practice, Taylor and Francis Group, New York, 121-139.
